123 related articles for article (PubMed ID: 386320)
21. Utilization of cultured human lymphoid cells for detection of humoral sensitization in prospective recipients of kidney transplants.
Ferrone S; Ting A; Pellegrino MA; Terasaki PI; Reisfeld RA
J Clin Invest; 1975 Feb; 55(2):388-94. PubMed ID: 1092715
[TBL] [Abstract][Full Text] [Related]
22. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
23. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes.
Tyler JD; Steinmuller D
J Immunol; 1981 May; 126(5):1759-63. PubMed ID: 7012238
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization.
Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB
Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465
[No Abstract] [Full Text] [Related]
25. Cellular and humoral immunity after clinical renal transplantation.
Arnesen E; Bondevik H; Thorsby E
Proc Eur Dial Transplant Assoc; 1975; 11():343-50. PubMed ID: 1105555
[TBL] [Abstract][Full Text] [Related]
26. The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.
Husberg BS
Clin Exp Immunol; 1972 Apr; 10(4):697-711. PubMed ID: 4556105
[TBL] [Abstract][Full Text] [Related]
27. Reactions of kidney cells with cytotoxic antisera: possible evidence of kidney-specific antigens.
Perkins HA; Gantan Z; Siegel S; Howell E; Belzer FO; Kountz SL
Tissue Antigens; 1975 Apr; 5(2):89-98. PubMed ID: 1093285
[TBL] [Abstract][Full Text] [Related]
28. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
Lowry RP; Gurley KE
Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
[TBL] [Abstract][Full Text] [Related]
29. Immune mechanisms in organ allograft rejection. II. T helper cells, delayed-type hypersensitivity, and rejection of renal allografts.
Gurley KE; Lowry RP; Forbes RD
Transplantation; 1983 Oct; 36(4):401-5. PubMed ID: 6226134
[TBL] [Abstract][Full Text] [Related]
30. Immunologic monitoring of the renal transplant recipient.
Suthanthiran M; Garovoy MR
Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
[No Abstract] [Full Text] [Related]
31. Recent advances in the understanding of rejection.
Hamburger J
Adv Nephrol Necker Hosp; 1975; 5():101-14. PubMed ID: 127520
[No Abstract] [Full Text] [Related]
32. Allogeneic inhibition in tolerant animals.
Möller E; Lapp W; Lindholm L
Transplant Proc; 1969 Mar; 1(1):543-7. PubMed ID: 4944269
[No Abstract] [Full Text] [Related]
33. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
[TBL] [Abstract][Full Text] [Related]
34. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
[TBL] [Abstract][Full Text] [Related]
35. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
36. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
Hargrave SL; Mayhew E; Hegde S; Niederkorn J
Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
[TBL] [Abstract][Full Text] [Related]
37. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice.
Nagata S; Okano S; Yonemitsu Y; Nakagawa K; Tomita Y; Yoshikai Y; Shimada M; Maehara Y; Sueishi K
Transplantation; 2006 Sep; 82(5):689-98. PubMed ID: 16969294
[TBL] [Abstract][Full Text] [Related]
38. Some comments on lymphocyte-mediated cytotoxicity and blocking serum activity in allograft tolerance.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():301-5. PubMed ID: 4607384
[No Abstract] [Full Text] [Related]
39. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
40. Antibody-dependent cell-mediated cytotoxicity in prospective kidney transplant recipients.
Lightbody JJ; Rosenberg JC
J Immunol; 1974 Mar; 112(3):890-6. PubMed ID: 4590706
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
